EXELON 9.5 MG/24HR PATCH

rivastigmine
$21.5451per EA
High Outlier

Strength

9.5 mg/24h

NDC

00078050215

Classification

Brand

Dosage Form

PATCH, EXTENDED RELEASE

Route

TRANSDERMAL

Last Updated

4/22/2026

Active Ingredients

RIVASTIGMINE

Approval Type

New Drug (NDA)

FDA Application

NDA022083

On Market Since

7/6/2007

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price History

1W

0.0%

1M

-1.7%

3M

-1.7%

6M

-1.7%

1Y

-1.8%

3Y

-2.4%

5Y

-2.0%

All

+112.5%